Company Sernova Toronto S.E.

Stocks

SVA

CA81732W1041

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E. Other stock markets 15:10:16 2026-07-09 EDT			5-day change	1st Jan Change
0.1300 ^CAD	0.00%		0.00%	-

06-17	Sernova's Autologous Islet Transplantation Gets Orphan Drug Designation For Type 3c Diabetes Prevention	MT
06-11	Sernova Biotherapeutics Inc Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2026	CI

Business description: Sernova

Sernova Biotherapeutics Inc. is a Canada-based clinical-stage company, which is focused on developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cell-derived cell therapies to create bio-hybrid organs to treat chronic diseases. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.

Sales by Activity: Sernova

Fiscal Period: October	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)

See all business segments

Geographical breakdown of sales: Sernova

Fiscal Period: October	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)

See all geographic segments

Executive Committee: Sernova

Manager	Title	Age	Since
Jonathan Rigby CEO	Chief Executive Officer	58	2024-08-11
James Parsons DFI	Director of Finance/CFO	60	2024-10-10
David Burke IRC	Investor Relations Contact	-	2024-10-10
Marie Kaldchibachi PRN	Corporate Officer/Principal	-	-
Gary Floyd SEC	Corporate Secretary	-	-

See SERNOVA governance

Composition of the Board of Directors: Sernova

Director	Title	Age	Since
Tanya Lewis BRD	Director/Board Member	55	-
John Brooks CHM	Chairman	75	2025-09-22
James Parsons BRD	Director/Board Member	60	2012-04-18
Steven Sangha BRD	Director/Board Member	-	2023-04-23
Bernd Mühlenweg BRD	Director/Board Member	54	2024-03-31
David Paterson BRD	Director/Board Member	-	2024-08-31

Composition of the Board of Directors

Shareholders: Sernova

Name	Stocks	%	Valuation
Steven Sangha 14.29 %	49,703,667	14.29 %	5 M $
James Parsons 0.1767 %	614,605	0.1767 %	66 377 $
Jonathan Rigby 0.0661 %	229,877	0.0661 %	24 827 $
CATAM Asset Management AG 0.0431 %	150,000	0.0431 %	16 200 $
Modestus Obochi 0.0144 %	50,000	0.0144 %	5 400 $

List of SERNOVA shareholders

Company details: Sernova

Sernova Biotherapeutics, Inc.

700 Collip Circle

N6G 4X8, London

+917-751-5713

http://www.sernova.com

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STRYKER CORPORATION	+0.08%	+0.17%	-16.56%	+11.16%	125B
SMITH & NEPHEW PLC	+0.40%	+0.36%	+1.39%	-2.84%	12.77B
GLAUKOS CORPORATION	+1.38%	+4.54%	+48.08%	+123.99%	9.1B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.14%	-4.12%	-49.87%	-73.56%	3.81B
DOUBLE MEDICAL TECHNOLOGY INC.	+3.78%	+3.24%	+24.09%	+46.10%	2.7B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-2.15%	-5.93%	-14.51%	-21.58%	1.73B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.21%	-0.95%	-3.75%	-25.72%	1.59B
INSPIRE MEDICAL SYSTEMS, INC.	+4.50%	+9.73%	-61.68%	-83.46%	1.48B
Average	+0.83%	+0.21%	-9.10%	-3.24%	19.82B
Weighted average by Cap.	+0.23%	+0.60%	-11.79%	+13.46%